TOT BIOPHARM International Company Limited
Equities
1875
HK0000545266
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.52 HKD | +0.66% | -7.32% | -22.84% |
Mar. 15 | TOT BIOPHARM International Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | TOT Biopharm's Loss Narrows in January-September Period | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-22.84% | 149M | |
-3.30% | 102B | |
+1.79% | 96.84B | |
-0.44% | 21.48B | |
-18.35% | 20.82B | |
-7.45% | 18.6B | |
-40.31% | 16.81B | |
-26.84% | 13.78B | |
+0.59% | 13.4B | |
+20.86% | 11.06B |
- Stock Market
- Equities
- 1875 Stock
- News TOT BIOPHARM International Company Limited
- TOT Biopharm Narrows Loss in January-September as Revenue Doubles; Shares Rally 4%